Show simple item record

dc.contributor.authorDi Pietro, Massimiliano
dc.contributor.authorModolell, Ines
dc.contributor.authorO'Donovan, Maria
dc.contributor.authorPrice, Catherine
dc.contributor.authorPilonis, Nastazja D
dc.contributor.authorDebiram-Beecham, Irene
dc.contributor.authorFitzgerald, Rebecca
dc.date.accessioned2020-09-10T11:15:41Z
dc.date.available2020-09-10T11:15:41Z
dc.date.issued2020-09
dc.identifier.issn2468-1253
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/310111
dc.description.abstractDuring the COVID-19 pandemic, endoscopy services have been severely curtailed—eg, in England, UK, a 30% reduction of diagnostic endoscopies has been reported for the period between January and April, 2020, compared with the same period in 2019, with an estimated 750 oesophagogastric cancers going undiagnosed. A delay in oesophageal cancer diagnosis could adversely affect outcomes, such as has previously been seen with low endoscopy referral rates being linked with poor outcomes from oesophageal cancer.
dc.languageeng
dc.publisherElsevier
dc.rightsAll rights reserved
dc.titleUse of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic.
dc.typeArticle
prism.endingPage806
prism.issueIdentifier9
prism.publicationDate2020
prism.publicationNameThe Lancet Gastroenterology and Hepatology
prism.startingPage805
prism.volume5
dc.identifier.doi10.17863/CAM.57195
dcterms.dateAccepted2020-07-20
rioxxterms.versionofrecord10.1016/S2468-1253(20)30242-9
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2020-09
dc.contributor.orcidDi Pietro, Massimiliano [0000-0003-4866-7026]
dc.contributor.orcidFitzgerald, Rebecca [0000-0002-3434-3568]
dc.identifier.eissn2468-1253
rioxxterms.typeJournal Article/Review
cam.issuedOnline2020-07-30
rioxxterms.freetoread.startdate2021-07-30


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record